Target is recalling several Up & Up baby wipes products sold nationwide after testing identified potentially dangerous bacteria that could cause serious infections, particularly in infants and young children.

According to a recall notice posted Friday by the U.S. Food and Drug Administration (FDA), Target is voluntarily recalling certain lots of Up & Up Fragrance Free Baby Wipes and Up & Up Fresh Cucumber Scented Baby Wipes following customer complaints about product discoloration.

FDA testing identified the presence of Burkholderia cepacia complex and Burkholderia gladioli in samples of the affected wipes.

Health officials warned that products contaminated with the bacteria could lead to serious and potentially life-threatening infections. The wipes are primarily used on newborns, infants and young children, a group considered particularly vulnerable because of their developing immune systems.

TARGET TO CUT PRICES ON 3,000 ITEMS AS INFLATION REMAINS ABOVE FED TARGET

Up & Up Fragrance Free Baby Wipes sold at Target stores nationwide are included in a voluntary recall announced June 2026. (FDA / Unknown)

The FDA said healthy individuals who use the contaminated wipes on skin with minor cuts or abrasions may develop localized infections. However, infections in immunocompromised individuals, newborns and infants could spread into the bloodstream and potentially cause sepsis or pneumonia.

The recalled wipes were manufactured by supplier Sapro Temizlik Urunleri and sold at Target stores nationwide as well as through Target.com.

Target and the manufacturer have received a number of consumer complaints and adverse event reports alleging product discoloration and symptoms including skin irritation, eye irritation and infections that may be linked to use of the wipes. The reports remain under investigation.

A representative for Target did not immediately respond to FOX Business’ request for comment.

TARGET SET TO OPEN ITS 2,000TH STORE, PLANS TO OPEN HUNDREDS MORE IN NEXT DECADE

A three-pack of Up & Up Fresh Cucumber Scented Baby Wipes is shown. Target is recalling certain baby wipes products after FDA testing identified potentially harmful bacteria in product samples. (FDA / Unknown)

The recall affects multiple sizes of Up & Up Fragrance Free Baby Wipes, including 20-count, 72-count, 216-count, 800-count and 1,200-count packages, as well as Up & Up Fresh Cucumber Scented Baby Wipes sold in 72-count, 216-count and 800-count packages.

Consumers are being urged to stop using the recalled wipes immediately and return them to any Target store for a full refund.

Target said customers seeking additional information can contact Target Guest Relations at 1-800-440-0680.

The recall is being conducted with the knowledge of the U.S. Food and Drug Administration, and Target said it is continuing to investigate the matter in coordination with the manufacturer.

According to the FDA, the affected Up & Up Fragrance Free Baby Wipes were manufactured between Nov. 7, 2025, and May 5, 2026, and carry expiration dates ranging from May 10, 2028, through Nov. 5, 2028.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The recalled Up & Up Fresh Cucumber Scented Baby Wipes were manufactured between Dec. 29 and Dec. 30, 2025, and carry expiration dates ranging from June 29, 2028, through June 30, 2028.

A complete list of affected UPCs, manufacturing codes and package sizes is available in the FDA recall notice.

Tim Goodnow
President, CEO & Director

Thanks for joining us. And as we update you folks on the Senseonics story, it’s a pretty exciting time for us. As many of you know, for those that were able to join us a year ago, we had a partnership with the PHC Corporation for the commercial activities. We’ve transitioned that since we last spoke. And it’s a pretty exciting time for us as we’ve been able to leverage that experience and that capability significantly with our strategic investment into the commercial organization. And frankly, we’re very excited with the commercial results that we’re now getting.

So obviously, the control of our destiny is very, very important, because it gives us the ability to pivot and move quick, make adjustments, expand those areas that make the most sense and frankly, leverage the internal capability. But we’ve been able to do that because, although we did the transition, we’ve essentially brought the entire Ascensia commercial organization over under Brian’s leadership, and that really has made a seamless process that we’ve been very excited to be able to execute against.

We also made the decision as part of that transition in the last year that the primary issue for growth with Eversense in a highly competitive market, but a very attractive market really had to

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of STK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in BAC over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of RYCEY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.